Task 3.7
GMP production of a new tracer vehicle...
Description
Based on results obtained in WP3-5, one or two of the new compounds will be produced under GMP conditions, labelled with a PET-radionuclide or IRDye800CW and tested in a first-in-human study in Task 6.8. The development of peptide tracers will be sup...
General Design
- Type
- Cohort study
- Start/End data collection
- not available
Organisations
Lead organisations
- F. HOFFMANN-LA ROCHE AGSwitzerlandhttps://www.roche.com/
- STICHTING VUMC (P1)Netherlands (the)https://www.vumc.nl/
- TAKEDA DEVELOPMENT CENTRE EUROPE LTDUnited Kingdom of Great Britain and Northern Ireland (the)
- University Medical Centre Groningen (UMCG)Netherlands (the)https://www.umcg.nl/
- VRIJE UNIVERSITEIT BRUSSELBelgiumhttps://www.vub.be/en/home
- WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTERGermanyhttps://www.uni-muenster.de/en/
Networks
Part of networks...